Whitebox Advisors LLC Trims Holdings in Acadia Healthcare Company, Inc. $ACHC

Whitebox Advisors LLC lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 36.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,955 shares of the company’s stock after selling 17,500 shares during the quarter. Whitebox Advisors LLC’s holdings in Acadia Healthcare were worth $701,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare in the 1st quarter worth about $1,600,000. Goldman Sachs Group Inc. lifted its position in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares in the last quarter. American Century Companies Inc. grew its stake in Acadia Healthcare by 531.5% in the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after purchasing an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. increased its holdings in Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after buying an additional 1,780 shares during the last quarter.

Analyst Upgrades and Downgrades

Several analysts have issued reports on ACHC shares. Royal Bank Of Canada upped their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Cantor Fitzgerald boosted their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Finally, Barclays boosted their target price on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus price target of $28.69.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $34.51 on Monday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a 50 day moving average of $27.64 and a 200-day moving average of $23.24. The firm has a market capitalization of $3.17 billion, a PE ratio of -2.82, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same quarter last year, the business posted $0.40 EPS. The business’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.